Inscription Capital, LLC Abb Vie Inc. Transaction History

Inscription Capital, LLC

$613 Million
Q2 2024

A detailed history of Inscription Capital, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Inscription Capital, LLC holds 18,944 shares of ABBV stock, worth $3.73 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

18,944

Previous 19,180 1.23%

Holding current value

$3.73 Million

Previous $3.49 Million 6.96%

% of portfolio

0.53%

Previous 0.58%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	SELL	$154.79 - $180.76 $36,530 - $42,659	-236 Reduced 1.23%	18,944 $3.25 Million
Q1 2024 Jul 17, 2024	SELL	$159.82 - $182.1 $10,388 - $11,836	-65 Reduced 0.34%	19,180 $3.49 Million
Q1 2024 Apr 10, 2024	BUY	$159.82 - $182.1 $531,880 - $606,028	3,328 Added 20.91%	19,245 $3.5 Million
Q4 2023 Jan 18, 2024	BUY	$137.6 - $154.97 $62,057 - $69,891	451 Added 2.92%	15,917 $2.47 Million
Q3 2023 Oct 17, 2023	BUY	$133.59 - $154.65 $56,642 - $65,571	424 Added 2.82%	15,466 $2.31 Million
Q2 2023 Jul 14, 2023	SELL	$132.51 - $164.9 $47,571 - $59,199	-359 Reduced 2.33%	15,042 $2.03 Million
Q1 2023 May 02, 2023	BUY	$144.61 - $166.54 $95,731 - $110,249	662 Added 4.49%	15,401 $2.45 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $11,479 - $13,767	-83 Reduced 0.56%	14,739 $2.38 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $1.99 Million - $2.29 Million	-14,846 Reduced 50.04%	14,822 $1.99 Million
Q2 2022 Sep 20, 2022	BUY	$137.62 - $174.96 $1.9 Million - $2.42 Million	13,831 Added 87.33%	29,668 $4.54 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $33,918 - $42,083	-257 Reduced 1.6%	15,837 $2.57 Million
Q4 2021 Feb 10, 2022	BUY	$107.43 - $135.93 $184,779 - $233,799	1,720 Added 11.97%	16,094 $2.18 Million
Q3 2021 Nov 09, 2021	SELL	$106.4 - $120.78 $2.49 Million - $2.82 Million	-23,372 Reduced 61.92%	14,374 $1.55 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $2.4 Million - $2.67 Million	22,771 Added 152.06%	37,746 $4.25 Million
Q1 2021 May 18, 2021	SELL	$102.3 - $112.62 $77,952 - $85,816	-762 Reduced 4.84%	14,975 $1.62 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $39,037 - $52,704	-485 Reduced 2.99%	15,737 $1.69 Million
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $4,725 - $5,545	55 Added 0.34%	16,222 $1.42 Million
Q2 2020 Aug 11, 2020	SELL	$73.37 - $98.18 $30,155 - $40,351	-411 Reduced 2.48%	16,167 $1.59 Million
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $18,898 - $28,652	-293 Reduced 1.74%	16,578 $1.26 Million
Q4 2019 Feb 04, 2020	BUY	$72.13 - $90.25 $163,735 - $204,867	2,270 Added 15.55%	16,871 $1.49 Million
Q3 2019 Nov 01, 2019	BUY	$62.98 - $75.72 $919,570 - $1.11 Million	14,601 New	14,601 $1.11 Million
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $52,625 - $67,267	-801 Closed	0 $0
Q1 2019 May 16, 2019	SELL	$77.14 - $90.79 $19,747 - $23,242	-256 Reduced 24.22%	801 $65,000
Q4 2018 May 16, 2019	BUY	$77.85 - $96.01 $82,287 - $101,482	1,057 New	1,057 $97,000

Others Institutions Holding ABBV

# of Institutions

3,696

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $348B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Inscription Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inscription Capital, LLC with notifications on news.

Account

Inscription Capital, LLC Abb Vie Inc. Transaction History